Elanco logo in a graphic reading Investor News
4 January 2022

Elanco to Participate in the 40th Annual J.P. Morgan Healthcare Conference


GREENFIELD, Ind. (January 4, 2022) Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022. Jeff Simmons, president and CEO, will represent the company and respond to questions from analysts. He is scheduled to present at 10:30 a.m. ET.

A live audio webcast will be available in the “Events and Presentations” section of Elanco’s investor website. A replay will be available for approximately 30 days.


Elanco Animal Health (NYSE: ELAN) is a global leader in animal health dedicated to innovating and delivering products and services to prevent and treat disease in farm animals and pets, creating value for farmers, pet owners, veterinarians, stakeholders, and society as a whole. With nearly 70 years of animal health heritage, we are committed to helping our customers improve the health of animals in their care, while also making a meaningful impact on our local and global communities. At Elanco, we’re driven by our vision of Food and Companionship Enriching life and our Elanco Healthy Purpose™ CSR framework – all to advance the health of animals, people and the planet. Learn more at www.elanco.com.

Investor Contact

Katy Grissom



Media Contact

Colleen Parr Dekker




Connect with Elanco

Country selector

Elanco and the diagonal bar logo are trademarks of Elanco or its affiliates. © 2022 Elanco.